VIB Nanobody Core validates Amperia™ for rapid his-tag nanobody quantification

The VIB Nanobody Core in Belgium supports nanobody discovery and development for academic and industrial partners, providing advanced screening and characterisation services for His-tagged proteins.

The team needed a faster and more reproducible way to quantify nanobody expression across large screening panels. Traditional ELISA workflows required multiple manual steps and long incubation times, limiting throughput and delaying data-driven selection.

Using the Amperia™ Protein Quantification System, nanobody samples were analysed directly from crude lysates, delivering quantitative results within the same day. The automated workflow provided accurate, reproducible measurements across a wide concentration range, with minimal hands-on time and no purification required.

Rapid, consistent data enabled the VIB team to prioritise high-yielding clones faster, streamlining nanobody screening and accelerating early development timelines.

 


 

Key Takeaways
  • Quantification of His-tagged nanobodies directly from crude lysates, with no purification required

  • Same-day quantitative results for large screening panels

  • Reliable performance across a wide dynamic range of expression levels

  • Consistent, reproducible data enabling faster identification of top-producing clones

  • Improved throughput and efficiency in nanobody screening workflows

Download The Document